Yang J Y, Togni M, Widmer U
Division of Clinical Immunology, Department of Medicine, University Hospital, CH-8091 Zurich, Switzerland.
Cytokine. 1999 Jan;11(1):1-7. doi: 10.1006/cyto.1998.0396.
CC chemokine receptor 5 (CCR5) is a cell entry cofactor for macrophage-tropic isolates of human immunodeficiency virus 1 (HIV-1). An inactive CCR5 allele with a 32-nucleotide deletion (CCR5Delta32) has been described that confers resistance to HIV-1 infection in homozygotes and slows the rate of progression to AIDS in heterozygotes. We found the allele CCR5Delta32 to be not rare in 399 Swiss blood donors with a frequency of 0.080. To assess the influence of defective CCR5 on production of its ligands we determined the capacity to produce the chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES in comparison with the production of the CXC chemokine IL-8 which does not bind to CCR5. Production of chemokines was determined during endotoxin stimulation of whole-blood samples ex vivo. Both, basal and LPS-induced chemokine production in 32 blood donors heterozygous for CCR5Delta32 were not significantly different when compared with 55 blood donors who were homozygous for the wild type CCR5 allele.
CC趋化因子受体5(CCR5)是人类免疫缺陷病毒1型(HIV-1)嗜巨噬细胞分离株进入细胞的辅助因子。已发现一种无活性的CCR5等位基因,其有32个核苷酸的缺失(CCR5Δ32),该等位基因使纯合子对HIV-1感染具有抗性,并减缓杂合子发展为艾滋病的速度。我们发现CCR5Δ32等位基因在399名瑞士献血者中并不罕见,频率为0.080。为了评估缺陷型CCR5对其配体产生的影响,我们测定了与不与CCR5结合的CXC趋化因子白细胞介素-8(IL-8)的产生相比,产生趋化因子巨噬细胞炎性蛋白(MIP)-1α、MIP-1β和调节激活正常T细胞表达和分泌因子(RANTES)的能力。趋化因子的产生是在体外对内毒素刺激的全血样本进行测定的。与55名野生型CCR5等位基因纯合的献血者相比,32名CCR5Δ32杂合的献血者的基础趋化因子产生和脂多糖(LPS)诱导的趋化因子产生均无显著差异。